Tag: health

  • Email interventions may offer a way to better wellbeing

    By Kathryn Doyle (Reuters Health) – An email-based program may help decrease stress and increase confidence and feelings of gratitude, according to an unusual study from Finland. It’s not clear how interesting these findings are, said Dr. Giovanni A. Fava of the University of Bologna and the State University of New York at Buffalo, who…

  • Teens with ADHD have special treatment needs

    By Lisa Rapaport (Reuters Health) – – Drugs and psychotherapy can help teens with attention deficit hyperactivity disorder (ADHD) manage symptoms and improve in school, a new research review suggests, but adolescents still have treatment needs that are quite distinct from younger children. Both stimulants and alternative medications can help reduce symptoms such as restlessness,…

  • Exclusive: Medivation succumbs to pressure to explore sale – sources

    U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to…

  • Allergan profit beats estimates, share buybacks planned

    The Dublin drugmaker on Tuesday said the planned $40 billion sale of its generics business to Teva Pharmaceutical Industries will close next month and that it will use $8 billion of the money to pay down company debt. Since the U.S. government torpedoed the merger, a deal that would have relocated Pfizer's legal domicile to…

  • Vaccines put brakes on yellow fever outbreaks, more may pop up: WHO

    By Tom Miles GENEVA (Reuters) – A major yellow fever outbreak in Angola and two smaller flare-ups in Uganda and Congo are largely under control but countries have been warned to be vigilant in case the disease pops up elsewhere, the World Health Organization (WHO) said on Tuesday. Yellow fever is hard to spot early…

  • Reliance on China health sector raises searching questions for Baidu

    By Paul Carsten BEIJING (Reuters) – The death of a student following experimental cancer treatment he found through China's biggest search engine, Baidu Inc , has exposed the faultlines in the company's business model, which relies heavily on income from the country's lightly regulated health sector. Before his death, student Wei Zexi, 21, criticized the…

  • Reliance on China health sector raises searching questions for Baidu

    By Paul Carsten BEIJING (Reuters) – The death of a student following experimental cancer treatment he found through China's biggest search engine, Baidu Inc , has exposed the faultlines in the company's business model, which relies heavily on income from the country's lightly regulated health sector. Before his death, student Wei Zexi, 21, criticized the…

  • Fight against AIDS threatened by lack of money, leadership, U.N. head says

    By Ellen Wulfhorst NEW YORK (Thomson Reuters Foundation) – Global progress fighting AIDS could be lost because prevention programs are suffering from a lack of leadership, accountability and funding, the head of the United Nations warned on Friday. Headway in tackling the epidemic has been “inspiring,” with a 42 percent decline in AIDS-related deaths since…

  • Sanofi, Amgen cholesterol drugs win UK backing after price cuts

    Two rival cholesterol-lowering injections from Sanofi and Amgen have been recommended by Britain's healthcare cost watchdog after the manufacturers offered special discounts to the country's state-run health service. Sanofi's Praluent, which was developed with Regeneron, and Amgen's Repatha are both so-called PCSK9 medicines that work in a different way to existing cholesterol fighters such as…

  • Sanofi, Amgen cholesterol drugs win UK backing after price cuts

    Two rival cholesterol-lowering injections from Sanofi and Amgen have been recommended by Britain's healthcare cost watchdog after the manufacturers offered special discounts to the country's state-run health service. Sanofi's Praluent, which was developed with Regeneron, and Amgen's Repatha are both so-called PCSK9 medicines that work in a different way to existing cholesterol fighters such as…